相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity
M. J. M. Gooden et al.
BRITISH JOURNAL OF CANCER (2014)
CXCL16 and CXCR6 in Ewing sarcoma family tumor
Ki Yong Na et al.
HUMAN PATHOLOGY (2014)
CLINICAL SIGNIFICANCE OF HMGB1 EXPRESSION IN HUMAN GASTRIC CANCER
J. Zhang et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2014)
The CXCL16-CXCR6 chemokine axis in glial tumors
Kirsten Hattermann et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Gastric cancer-molecular and clinical dimensions
Roopma Wadhwa et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
The transmembrane chemokines CXCL16 and CX3CL1 and their receptors are expressed in human meningiomas
Gu Li et al.
ONCOLOGY REPORTS (2013)
Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model
Ji-Ye Kee et al.
ONCOLOGY REPORTS (2013)
Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer
Yu Huang et al.
CHINESE JOURNAL OF CANCER (2013)
CXCR6 and CCR5 Localize T Lymphocyte Subsets in Nasopharyngeal Carcinoma
Greg Parsonage et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Soluble CXCL16 in Preoperative Serum is a Novel Prognostic Marker and Predicts Recurrence of Liver Metastases in Colorectal Cancer Patients
Kohei Matsushita et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma
Qiang Gao et al.
CANCER RESEARCH (2012)
T Lymphocyte Recruitment into Renal Cell Carcinoma Tissue: A Role for Chemokine Receptors CXCR3, CXCR6, CCR5, and CCR6
Kimberley A. Oldham et al.
EUROPEAN UROLOGY (2012)
Role and clinicopathologic significance of CXC chemokine ligand 16 and chemokine (C-X-C motif) receptor 6 expression in gastric carcinomas
Ya-nan Xing et al.
HUMAN PATHOLOGY (2012)
EXPRESSION OF PI3K/AKT PATHWAY IN GASTRIC CANCER AND ITS BLOCKADE SUPPRESSES TUMOR GROWTH AND METASTASIS
B. Ye et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2012)
CXCR6: The Role of Environment in Tumor Progression. Challenges for Therapy
Caterina A. M. La Porta
STEM CELL REVIEWS AND REPORTS (2012)
Expression and localization of CXCL16 and CXCR6 in ovarian endometriotic tissues
Shuichi Manabe et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2011)
The expression and role of CXC chemokines in colorectal cancer
Hannelien Verbeke et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma
Li Guo et al.
Chinese Journal of Cancer (2011)
Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients
Paul Gutwein et al.
EUROPEAN JOURNAL OF CANCER (2009)
Enhanced Tumor Metastasis in Response to Blockade of the Chemokine Receptor CXCR6 Is Overcome by NKT Cell Activation
Robyn Cullen et al.
JOURNAL OF IMMUNOLOGY (2009)
The Chemokine CXCL16 and Its Receptor, CXCR6, as Markers and Promoters of Inflammation-Associated Cancers
Merav Darash-Yahana et al.
PLOS ONE (2009)
Expression of p-Akt and COX-2 in Gastric Adenocarcinomas and Adenovirus Mediated Akt1 and COX-2 ShRNA Suppresses SGC-7901 Gastric Adenocarcinoma and U251 Glioma Cell Growth In Vitro and In Vivo
Jing Zhang et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2009)
被撤回的出版物: The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation (Retracted article. See vol. 71, pg. 1196, 2011)
Joost Meijer et al.
CANCER RESEARCH (2008)
CXCR6 Induces Prostate Cancer Progression by the AKT/Mammalian Target of Rapamycin Signaling Pathway
Jianhua Wang et al.
CANCER RESEARCH (2008)
CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells
Weidong Hu et al.
CANCER SCIENCE (2008)
Overexpression of CXCL16 and its receptor CXCR6/bonzo promotes growth of human schwannomas
Janka Held-Feindt et al.
GLIA (2008)
High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer
Shozo Hojo et al.
CANCER RESEARCH (2007)
分享论文
